(430) 770-2469 info@marvelbiotechnology.com
Marvel Biosciences
  • About Us
  • Technology
    • MB-204
    • Non-Hallucinogenic Neuroplasticity Program
  • News
  • Investors
  • Contact Us
Select Page

Investor Resources

2022 Annual General Meeting Documents for year end 2021

–

  • January 20, 2022 – Certificate of Abridgement
  • January 20, 2022 – Management Information Circular fiscal July 31 2021
  • January 20, 2022 – Notice of Meeting
  • Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) Profile (sedar.com)

Recent News

Events and Presentations

Corporate Presentation

  • Twitter
Copyright 2022 Marvel Biosciences Corp. All rights reserved.